Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Nov 30, 2021
Microfluidics have revolutionized...
Extensive assessment of Cytokine production on the NovoCyte Penteon flow cytometer
Nov 23, 2021
Cytokines are small molecules essential for immune cell response to activation by pathogens, autoimmunity, or...
Nov 10, 2021
Join our webinar to learn how...
Discover the advanced Detector Technology in Agilent NovoCyte flow cytometers
Nov 8, 2021
This technical overview describes advancements in detector technology, and highlights examples where optimal signal...
Oct 20, 2021
Ionizing radiation approaches are effective but use of radioactive radioisotopic elements have become difficult to...
Duke uses XRAD 225 CX to test radiosensitivity hypothesis
Oct 18, 2021
Image guided radiotherapy in a preclinical setting couldn’t be more useful than the treatment of brain tumors, where...
Curiox webinar: Laminar Wash enables single-cell multiomics and cell hashing
Oct 11, 2021
Professor Mats Bemark’s lab at the University of Gothenburg in Sweden studies how the immune system responds to...
Falling in love with Magnetic resonance
Oct 4, 2021
Magnetic Resonance (MR) is more than just analytical science, it is unique, it is a passion that won’t let you go
Protectome analysis: A new selective tool for bacterial vaccine discovery
Feb 28, 2018
Several laboratories have been trying to refine the original approach in order to get to the identification of the relevant antigens straight from the genome. Here we report a new bioinformatics tool that moves a first step in this direction. The tool has been developed by identifying structural/functional features recurring in known bacterial protective antigens, the so called “Protectome space,” and using such “protective signatures” for protective antigen discovery. In particular, we applied this new approach to Staphylococcus aureus and Group B Streptococcus and we show that not only already known protective antigens were re-discovered, but also two new protective antigens were identified.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
